Your browser doesn't support javascript.
loading
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial.
Strik, Anne S; van de Vrie, Wim; Bloemsaat-Minekus, Joanne P J; Nurmohamed, Michael; Bossuyt, Peter J J; Bodelier, Alexander; Rispens, Theo; van Megen, Yvonne J B; D'Haens, Geert R.
  • Strik AS; Department of Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • van de Vrie W; Department of Gastroenterology, Albert Schweitzer Hospital, Dordrecht, Netherlands.
  • Bloemsaat-Minekus JPJ; Mundipharma, Leusden, Netherlands.
  • Nurmohamed M; Department of Rheumatology, Reade, Amsterdam, Netherlands.
  • Bossuyt PJJ; Department of Gastroenterology, Imelda Hospital, Bonheiden, Belgium.
  • Bodelier A; Department of Gastroenterology, Amphia Hospital, Breda, Netherlands.
  • Rispens T; Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; Sanquin Research, Department of Immunopathology, Amsterdam, Netherlands.
  • van Megen YJB; Mundipharma, Leusden, Netherlands.
  • D'Haens GR; Department of Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. Electronic address: g.dhaens@amc.uva.nl.
Lancet Gastroenterol Hepatol ; 3(6): 404-412, 2018 06.
Article en En | MEDLINE | ID: mdl-29606564
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Enfermedad de Crohn / Biosimilares Farmacéuticos / Infliximab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Enfermedad de Crohn / Biosimilares Farmacéuticos / Infliximab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article